Lv0
0 积分 2023-09-15 加入
[Clinical practice guideline for molecular pathology in colorectal cancer (2025 version)]
17小时前
已完结
Exceptional Response to Crizotinib With Subsequent Response to Cabozantinib in Metastatic, ROS1-GOPC Fusion–Mutated Breast Cancer
14天前
已关闭
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
2个月前
已完结
[Mutation screening and prenatal diagnosis of tuberous sclerosis complex]
5个月前
已完结